Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice

BACKGROUND: New drugs for locally advanced or metastatic breast cancer have led to clinical benefits, aside with increasing costs to healthcare systems. The current financing model for health technology assessment (HTA) privileges real-world data. As part of the ongoing HTA, this study aimed to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves da Costa, Filipa, Cardoso Borges, Fábio, Ramos, Adriana, Mayer, Alexandra, Brito, Claudia, Ramos, Catarina, Bernardo, Catarina, Cossito, Mariane, Furtado, Cláudia, Ferreira, Arlindo R., Martins-Branco, Diogo, da Costa Miranda, Ana, Lourenço, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308630/
https://www.ncbi.nlm.nih.gov/pubmed/37386484
http://dx.doi.org/10.1186/s13058-023-01678-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308630/
https://www.ncbi.nlm.nih.gov/pubmed/37386484
http://dx.doi.org/10.1186/s13058-023-01678-5

Ejemplares similares